Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
Inleiding hoofdstuk lezen eerste hoofdstuk lezen

2023 | OriginalPaper | Hoofdstuk

9. Orgasmestoornissen bij mannen

Auteurs : Dr. Yacov Reisman, Prof. dr. Jacques van Lankveld

Gepubliceerd in: Seksuele problemen

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

In dit hoofdstuk worden twee mannelijke orgasmestoornissen beschreven: vroegtijdige zaadlozing (VZ) en geremd orgasme/geremde zaadlozing (GZ) met het doel om deze aandoeningen te kunnen vaststellen en behandelingsmogelijkheden toe te passen. Van vroegtijdige zaadlozing is sprake wanneer de ejaculatie eerder dan gewenst optreedt. Vroegtijdige zaadlozing is een veelvoorkomende seksuele klacht en veroorzaakt stress voor de patiënt en zijn partner. Dit hoofdstuk beschrijft de verschillende subtypes (syndromen) gerelateerd aan VZ, hun verschillen, klachten, oorzaken en behandelingsmogelijkheden. GZ is het aanhoudend ontbreken van orgasme volgend op een fase van seksuele activiteit met passende stimulatie en normale opwinding. Er zijn beperkte publicaties over GZ en de mogelijke oorzaken en de behandelmogelijkheden worden beschreven. Beide aandoeningen worden vanuit biopsychosociaal perspectief benaderd.
vorige hoofdstuk Erectieproblemen
volgende hoofdstuk Genitale pijn bij mannen
Literatuur
1.
Althof SE, McMahon CG, Waldinger MD, et al. An update of the International society of sexual medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med. 2014;2:60–90.CrossRef
2.
Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 1994;151(9):1377–9.CrossRef
3.
Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res. 1998;92(2):111–8.CrossRef
4.
Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005;2(4):492–7.CrossRef
5.
Waldinger MD, McIntosh J, Schweitzer DH. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J Sex Med. 2009;6(10):2888–95.CrossRef
6.
Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International society for sexual medicine ad hoc committee for the definition of premature ejaculation. J Sex Med. 2014;2:41–59.CrossRef
7.
APA. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
8.
Schapiro B. Premature ejaculation: a review of 1,130 cases. J Urol. 1943;50:374–9.CrossRef
9.
Godpodinoff ML. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther. 1989;15(2):130–4.CrossRef
10.
Althof SE, Symonds T. Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am 2007;34(4):581–589, vii.
11.
12.
Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II – Proposals for DSM-V and ICD-11. J Sex Med 2006;3(4):693–705.
13.
Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I – Validity of DSM-IV-TR. J Sex Med 2006;3(4):682–692.
14.
Waldinger MD. The need for a revival of psychoanalytic investigations into premature ejaculation. J Mens Health & Gender. 2006;3:390–6.CrossRef
15.
Waldinger MD, Schweitzer DH. The use of old and recent DSM definitions of premature ejaculation in observational studies: a contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med. 2008;5(5):1079–87.CrossRef
16.
Serefoglu EC. Prevalence of the four premature ejaculation syndromes: Results from the Turkish society of andrology sexual health survey. J Sex Med 2010.
17.
Serefoglu EC, Cimen HI, Atmaca AF, Balbay MD. The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes. J Sex Med. 2010;7(2 Pt 1):810–5.CrossRef
18.
19.
Côté-Léger P, Rowland DL. Estimations of typical, ideal, premature ejaculation, and actual latencies by men and female sexual partners of men during partnered sex. J Sex Med. 2020;17(8):1448–56.CrossRef
20.
Barbonetti A, D’Andrea S, Cavallo F, et al. Erectile dysfunction and premature ejaculation in homosexual and heterosexual men: a systematic review and meta-analysis of comparative studies. J Sex Med. 2019;16:624e632.
21.
Waldinger MD. The neurobiological approach to premature ejaculation. J Urol. 2002;168(6):2359–67.CrossRef
22.
Truitt WA, Coolen LM. Identification of a potential ejaculation generator in the spinal cord. Science. 2002;297(5586):1566–9.CrossRef
23.
Coolen LM, Allard J, Truitt WA, McKenna KE. Central regulation of ejaculation. Physiol Behav. 2004;83(2):203–15.CrossRef
24.
Waldinger MD, Rietschel M, Nothen MM, Hengeveld MW, Olivier B. Familial occurrence of primary premature ejaculation. Psychiatr Genet. 1998;8(1):37–40.CrossRef
25.
Janssen PK, Bakker SC, Rethelyi J, Zwinderman AH, Touw DJ, Olivier B, Waldinger MD. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med. 2009;6(1):276–84.CrossRef
26.
De Jong TR, Veening JG, Olivier B, Waldinger MD. Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies. J Sex Med. 2007;4(1):14–28.CrossRef
27.
Cihan A, Esen AA. Systematic review and meta-analysis for the value of thyroid disorder screening in men with ejaculatory dysfunction. Int J Clin Pract. 2021;75(10): e14419.CrossRef
28.
Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urol. 2001;58(2):198–202.CrossRef
29.
Rosen R, Althof S. Impact of premature ejaculation: the psychological quality of life and sexual relationship consequences. J Sex Med. 2008;5:1296–307.CrossRef
30.
Van Lankveld JJDM, Grotjohann Y. Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the Composite International Diagnostic Interview. Arch Sex Behav. 2000;29(5):479–98.CrossRef
31.
Rowland DL, Cooper SE, Slob AK. Genital and psychoaffective response to erotic stimulation in sexually functional and dysfunctional men. J Abn Psychol. 1996;105(2):194–203.CrossRef
32.
Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M. The interplay between premature ejaculation and erectile dysfunction: a systematic review and metaanalysis. J Sex Med. 2015;12:2291–300.CrossRef
33.
Rosen RC, Althof S. Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. J Sex Med. 2008;5(6):1296–307.CrossRef
34.
Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The premature ejaculation profile: validation of self-reported outcome measures for research and practice. BJU Int. 2009;103(3):358–64.CrossRef
35.
Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med. 2006;3(3):465–75.CrossRef
36.
Symonds T, Perelman M, Althof S, Giuliano F, Martin M, Abraham L, Crossland A, Morris M, May K. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res. 2007;19(5):521–5.CrossRef
37.
38.
Serefoglu EC, Cimen HI, Ozdemir AT, Symonds T, Berktas M, Balbay MD. Turkish validation of the premature ejaculation diagnostic tool and its association with intravaginal ejaculatory latency time. Int J Impot Res. 2009;21:139–44.CrossRef
39.
Rosen R, McMahon C, Niederberger C, Broderick G, Jamieson C, Gagnon DD. Correlates to the clinical diagnosis of premature ejaculation: results from a large observational study of men and their partners. J Urol. 2007;177:1059–64.CrossRef
40.
Porst H. Premature ejaculation. In: Reisman Y, Porst H et al., editors. The ESSM manual of sexual medicine. Amsterdam: Medix; 2015
41.
Waldinger MD. Premature ejaculation: different pathophysiologies and etiologies determine its treatment. J Sex Marital Ther. 2008;34(1):1–13.CrossRef
42.
Waldinger MD. Premature ejaculation: state of the art. Urol Clin North Am. 2007;34(4):591–599, vii–viii.
43.
Waldinger MD. Premature ejaculation: definition and drug treatment. Drugs. 2007;67(4):547–68.CrossRef
44.
45.
Waldinger MD, Schweitzer DH, Olivier B. On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med. 2005;2(1):121–31.CrossRef
46.
Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, Miloslavsky M, Kell S. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet. 2006;368(9539):929–37.CrossRef
47.
Waldinger MD, Schweitzer DH, Olivier B. Dapoxetine treatment of premature ejaculation. Lancet. 2006;368(9550):1869; author reply 1869–1870.
48.
Waldinger MD, Schweitzer DH. Premature ejaculation and pharmaceutical company based medicine: the dapoxetine case. J Sex Med. 2008;5(4):966–97.CrossRef
49.
Martyn-St James M, Cooper K, Kaltenthaler E, et al. Tramadol for premature ejaculation: a systematic review and metaanalysis. BMC Urol. 2015;15:6.PubMedCentralCrossRef
50.
Martyn-St James M, Cooper K, Ren K, et al. Topical anaesthetics for premature ejaculation: a systematic review and meta-analysis. Sex Health. 2016;13:114.CrossRef
51.
Gameel TA, Tawfik AM, Abou-Farha MO, et al. On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: a randomized placebo-controlled clinical trial. Arab J Urol. 2013;11:392–7.PubMedCentralCrossRef
52.
Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, Ahn TY. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7(4 Pt 2):1668–86.CrossRef
53.
Bai Y, et al. Selective serotonin reuptake inhibitors plus phosphodiesterase-5 inhibitors for premature ejaculation: a systematic review and meta-analysis. Urology. 2015;86:758.CrossRef
54.
Melnik T, Althof S, Atallah AN, Puga ME, Glina S, Riera R. Psychosocial interventions for premature ejaculation. Cochrane Database Syst Rev. 2011:CD008195.
55.
Steggall MJ, Fowler CG, Pryce A. Combination therapy for premature ejaculation: results of a small scale study. Sex Relation Ther. 2008;23:365–76.CrossRef
56.
Waldinger MD. Recent advances in the classification, neurobiology and treatment of premature ejaculation. Adv Psychosom Med. 2008;29:50–69.CrossRef
57.
De Amicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behavior. 1985;14:467–89.CrossRef
58.
Althof SE. Psychosexual therapy for premature ejaculation. Transl Androl Urol. 2016;5:475–481.
59.
Jannini EA, Simonelli C, Lenzi A. Sexological approach to ejaculatory dysfunction1. Int J Androl. 2002;25:317–23.CrossRef
60.
Masters W, Johnson V. Human sexual inadequacy. Boston, MA: Little, Brown; 1970.
61.
Semans JH. Premature ejaculation: a new approach. South Med J. 1956;49:353–8.CrossRef
62.
Pastore AL, Palleschi G, Fuschi A, et al. Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: a novel therapeutic approach. Ther Adv Urol. 2014;6:83–8.PubMedCentralCrossRef
63.
La Pera G. Awareness and timing of pelvic floor muscle contraction, pelvic exercises and rehabilitation of pelvic floor in lifelong premature ejaculation: 5 years experience. Arch Ital Urol E Androl. 2014;86:123.CrossRef
64.
Lavoisier P, Roy P, Dantony E, et al. Pelvic-floor muscle rehabilitation in erectile dysfunction and premature ejaculation. Phys Ther. 2014;94:1731–43.CrossRef
65.
Haensel SM, Rowland DL, Kallan KT, Slob AK. An exploration of emotional response to erotic stimulation in men with premature ejaculation: effects of treatment with clomipramine. J Urol. 1996;156(4):1310–5.CrossRef
66.
Liu H, Zhang M, Huang M, et al. Comparative efficacy and safety of drug treatment for premature ejaculation: a systemic review and Bayesian network meta-analysis. Andrologia. 2020;52(11): e13806.CrossRef
67.
Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004;16(4):369–81.CrossRef
68.
McMahon CG, Jannini E, Waldinger M, Rowland D. Standard operating procedures in the disorders of orgasm and ejaculation. J Sex Med. 2013;10:204–29.CrossRef
69.
70.
Burri A, Buchmeier J, Porst H. The importance of male ejaculation for female sexual satisfaction and orgasm ability. J Sex Med. 2018;15(7):123.CrossRef
71.
Shindel AW. Anejaculation: relevance to sexual enjoyment in men and women. J Sex Med. 2019;16:1324–7.CrossRef
72.
Kedde H, De Haas S. Problemen met het seksueel functioneren. In: F Bakker, I Vanwesenbeeck, editors, Seksuele gezondheid in Nederland 2006 (pp. 123–137). Delft: Eburon; 2006.
73.
De Graaf H, Wijsman C. Seksuele gezondheid in Nederland 2017. Rutgers; 2017.
74.
Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav. 2001;30(2):177–219.PubMedCentralCrossRef
75.
76.
Sandfort TGM, De Keizer M. Sexual problems in gay men: an overview of empirical research. Ann Rev Sex Res. 2001;12:93–120.
77.
Alexander M, Rosen RC. Spinal cord injuries and orgasm: a review. J Sex Marital Ther. 2008;34(4):308–24.CrossRef
78.
Perelman MA, Rowland DL. Retarded ejaculation. World J Urol. 2006;24:645–52.CrossRef
79.
Sadowski DJ, Butcher MJ, Köhler TS. A review of pathophysiology and management options for delayed ejaculation. Sex Med Rev. 2016;4:167–76.CrossRef
80.
Althof SE. Psychological interventions for delayed ejaculation/orgasm. Int J Impot Res. 2012;24:131–6.CrossRef
81.
Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 1999;19(3):268–71.CrossRef
82.
Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA. 2003;289(1):56–64.CrossRef
83.
Abdel-Hamid IA, El Saleh S. Primary lifelong delayed ejaculation: characteristics and response to bupropion. J Sex Med. 2011;8:1772–9.CrossRef
84.
Ashton AK, Hamer R, Rosen RC. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther. 1997;23:165–75.CrossRef
85.
86.
Corona G, Isidori AM, Buvat J, Aversa A, Rastrelli G, Hackett G, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014;11:1577–92.CrossRef
87.
Nelson CJ, Ahmed A, Valenzuela R, Parker M, Mulhall JP. Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm. Urology. 2007; 69:552–5. discussion 5–6.
88.
Ohl DA, Sonksen J, Brackett NL, Lynne CH. Electroejaculation: A state of the art review. Curr Sex Health Rep. 2007;4:93–7.CrossRef
Metagegevens
Titel
Orgasmestoornissen bij mannen
Auteurs
Dr. Yacov Reisman
Prof. dr. Jacques van Lankveld
Copyright
2023
Uitgeverij
Bohn Stafleu van Loghum
Boek
Seksuele problemen

Print ISBN: 978-90-368-2893-2

Elektronisch ISBN: 978-90-368-2894-9

Copyright: 2023

DOI
https://doi.org/10.1007/978-90-368-2894-9_9